BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 30922600)

  • 41. [Biliary cast syndrome in non-liver surgery patients].
    Ha SI; Choi JS; Kim YH; Jun HS; Jo YG; Lee WH; Park SG; Lee SH
    Korean J Gastroenterol; 2012 Dec; 60(6):382-5. PubMed ID: 23242023
    [TBL] [Abstract][Full Text] [Related]  

  • 42.
    Biyoukar M; Corpechot C; El Mouhadi S; Chambenois E; Vanderbecq Q; Barbu V; Dong C; Lemoinne S; Tordjman M; Jomaah R; Chazouilleres O; Arrivé L
    JHEP Rep; 2022 Nov; 4(11):100590. PubMed ID: 36277956
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Primary sclerosing cholangitis].
    Benhamou JP
    Rev Prat; 2000 Dec; 50(19):2146-9. PubMed ID: 11213459
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ABCB4 gene mutation-associated cholelithiasis in adults.
    Rosmorduc O; Hermelin B; Boelle PY; Parc R; Taboury J; Poupon R
    Gastroenterology; 2003 Aug; 125(2):452-9. PubMed ID: 12891548
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Should patients with symptomatic cholelithiasis before 30 years of age be tested for
    Gouveia C; Flor de Lima M; Pereira F; Rosa B; Cotter J; Banhudo A; Duarte M; Ferreira A; Cravo M; Nunes J
    Scand J Gastroenterol; 2020 Aug; 55(8):958-962. PubMed ID: 32650689
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of long-term results and recurrent factors after operative and nonoperative treatment for hepatolithiasis.
    Cheon YK; Cho YD; Moon JH; Lee JS; Shim CS
    Surgery; 2009 Nov; 146(5):843-53. PubMed ID: 19744434
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biliary tract inflammatory disorders: primary sclerosing cholangitis and primary biliary cirrhosis.
    Franco J; Saeian K
    Curr Gastroenterol Rep; 1999 Apr; 1(2):95-101. PubMed ID: 10980934
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Primary sclerosing cholangitis.
    Geonzon-Gonzales MR
    Gastroenterol Nurs; 2007; 30(2):102-5; quiz 105-7. PubMed ID: 17440311
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reversal of advanced fibrosis after long-term ursodeoxycholic acid therapy in a patient with residual expression of MDR3.
    Frider B; Castillo A; Gordo-Gilart R; Bruno A; Amante M; Alvarez L; Mathet V
    Ann Hepatol; 2015; 14(5):745-51. PubMed ID: 26256905
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ABCB4 mutations underlie hormonal cholestasis but not pediatric idiopathic gallstones.
    Jirsa M; Bronský J; Dvořáková L; Šperl J; Šmajstrla V; Horák J; Nevoral J; Hřebíček M
    World J Gastroenterol; 2014 May; 20(19):5867-74. PubMed ID: 24914347
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combined features of low phospholipid-associated cholelithiasis and progressive familial intrahepatic cholestasis 3.
    Poupon R; Barbu V; Chamouard P; Wendum D; Rosmorduc O; Housset C
    Liver Int; 2010 Feb; 30(2):327-31. PubMed ID: 19840255
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term outcome of percutaneous transhepatic cholangioscopic lithotomy for hepatolithiasis.
    Huang MH; Chen CH; Yang JC; Yang CC; Yeh YH; Chou DA; Mo LR; Yueh SK; Nien CK
    Am J Gastroenterol; 2003 Dec; 98(12):2655-62. PubMed ID: 14687812
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Primary biliary cirrhosis. Primary sclerosing cholangitis].
    Corpechot C; Chazouilleres O
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 1):325-32. PubMed ID: 12769103
    [No Abstract]   [Full Text] [Related]  

  • 54. Liver diseases related to MDR3 (ABCB4) gene deficiency.
    Gonzales E; Davit-Spraul A; Baussan C; Buffet C; Maurice M; Jacquemin E
    Front Biosci (Landmark Ed); 2009 Jan; 14(11):4242-56. PubMed ID: 19273348
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases.
    Trauner M; Fickert P; Halilbasic E; Moustafa T
    Wien Med Wochenschr; 2008; 158(19-20):542-8. PubMed ID: 18998069
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?
    Hay JE
    Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S9-17. PubMed ID: 9742489
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Percutaneous treatment of intrahepatic lithiasis].
    Bonnel D; Liguory C; Lefebvre JF; Cornud F
    Gastroenterol Clin Biol; 2001; 25(6-7):581-8. PubMed ID: 11673726
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endoscopic assessment of primary sclerosing cholangitis.
    De Vries B; Weersma RK
    Minerva Gastroenterol Dietol; 2016 Mar; 62(1):49-62. PubMed ID: 26446685
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An Update on the Treatment and Follow-up of Patients with Primary Biliary Cholangitis.
    Burman BE; Jhaveri MA; Kowdley KV
    Clin Liver Dis; 2017 Nov; 21(4):709-723. PubMed ID: 28987258
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Choice and modalities of the treatment of biliary lithiasis].
    Malè PJ; Meyer P
    Schweiz Med Wochenschr; 1986 Aug; 116(31-32):1040-4. PubMed ID: 3749841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.